Page last updated: 2024-09-03
garenoxacin and Prostatic Neoplasms
garenoxacin has been researched along with Prostatic Neoplasms in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kobayashi, M; Nakamura, M; Ohmori, S; Yaguchi, T | 1 |
Other Studies
1 other study(ies) available for garenoxacin and Prostatic Neoplasms
| Article | Year |
|---|---|
Primary cutaneous nocardiosis caused by Nocardia beijingensis in an immunocompromised patient with chemotherapy for advanced prostate cancer.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Fluoroquinolones; Humans; Immunocompromised Host; Male; Nocardia; Nocardia Infections; Prednisolone; Prostatic Neoplasms; Severity of Illness Index; Taxoids; Treatment Outcome | 2012 |